Quality assurance of drugs used in clinical trials: proposal for adapting guidelines

Paul N. Newton; David Schellenberg; Elizabeth A. Ashley; Raffaella Ravinetto; Michael D. Green; Feiko O. ter Kuile; Patricia Tabernero; Sir Nicholas White; Philippe J. Guérin

doi:10.1136/bmj.h602

Related publications

Article2009

Guidelines for Field Surveys of the Quality of Medicines: A Proposal

Paul N. Newton, Sue J. Lee, Catherine Goodman, Facundo M. Fernández, Shunmay Yeung, Souly Phanouvong, Harparkash Kaur, Abdinasir A Amin, C. W. M. Whitty, Gilbert Kokwaro, Niklas Lindegårdh, Patrick Lukulay, Lisa J. White, Nicholas Day, Michael D. Green, Sir Nicholas White

PLoS Medicine

Article2011

The Primacy of Public Health Considerations in Defining Poor Quality Medicines

Paul N. Newton, Abdinasir A Amin, Chris Bird, Phillip Raymond Passmore, Graham Dukes, Göran Tomson, Bright Simons, Roger Bate, Philippe J. Guérin, Sir Nicholas White

PLoS Medicine

Article2021

Evaluation of the reporting quality of clinical practice guidelines on pancreatic cancer using the RIGHT checklist

Qiwen Zhang, Jingli Lü, Mengmeng Jia, Yanfang Ma, Mingyang Sun, Xiaoxu Chen, Xiaohua Ma, Yongjie Yang, Jian Jian Kang, Xiaojian Zhang, Salvatore Paiella, Matthew H. G. Katz, Kunihiro Tsuchida, Mark Schattner, Shuzhang Du

Article1994

A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group

Erik Andrew, Aslam H. Anis, Mildred K. Cho, Mike Clarke, David T. Felson, Peter C Gøtzsche, Richard E. Greene, Alejandro R. Jadad, Wayne B. Jonas, Terry P. Klassen, Paul Knipschild, Andreas Laupacis, Curtis L. Meinert, David Moher, Graham Nichol, Andy Oxman, Marie-France Penman, Stuart Pocock, Joan Reisch, David L. Sackett, Kenneth F. Schulz, Judy Snider, Peter Tugwell,

Article2010

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal

David M. Kent, Peter M. Rothwell, John P A Ioannidis, Doug Altman, Rodney A. Hayward